Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
2013 · Proceedings of the National Academy of Sciences · 1,919 citations
https://doi.org/10.1073/pnas.1320318110
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
3.9K
Citations
11
h-index
11
i10-index
James O. Jones is an academic researcher from University of Cambridge. The author has contributed to research in topics: Renal cell carcinoma treatment & Renal and related cancers & Cancer Immunotherapy and Biomarkers. The author has an h-index of 11, co-authored 42 publications.
ORCID: 0000-0002-2194-4903Click to start Chat